AstraZeneca plc ADR

Historical 13F Holders

Symbol
AZN
CUSIP
046353108
All holders as of
Q2 2025
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 1,256 500 M $34.8 B
2025 Q1 1,294 508 M $37.8 B
2024 Q4 1,259 515 M $33.7 B
2024 Q3 1,282 506 M $39.4 B
2024 Q2 1,259 516 M $40.3 B
2024 Q1 1,192 531 M $36.0 B
2023 Q4 1,178 520 M $35.0 B
2023 Q3 1,128 497 M $33.8 B
2023 Q2 1,154 503 M $37.0 B
2023 Q1 1,114 519 M $35.7 B
2022 Q4 1,121 514 M $35.3 B
2022 Q3 1,027 521 M $28.6 B
2022 Q2 1,064 529 M $35.0 B
2022 Q1 1,028 517 M $34.3 B
2021 Q4 1,014 505 M $29.4 B
2021 Q3 976 517 M $31.1 B
2021 Q2 830 434 M $26.1 B
2021 Q1 812 411 M $20.5 B
2020 Q4 849 400 M $20.1 B
2020 Q3 773 408 M $22.4 B
2020 Q2 721 428 M $22.7 B
2020 Q1 639 442 M $19.8 B
2019 Q4 679 447 M $22.3 B
2019 Q3 593 458 M $20.4 B
2019 Q2 605 461 M $19.1 B
2019 Q1 599 478 M $19.3 B
2018 Q4 595 466 M $17.7 B
2018 Q3 590 441 M $17.5 B
2018 Q2 574 413 M $14.5 B
2018 Q1 564 398 M $13.9 B
2017 Q4 547 385 M $13.4 B
2017 Q3 500 375 M $12.7 B
2017 Q2 537 361 M $12.3 B
2017 Q1 518 358 M $11.2 B
2016 Q4 502 320 M $8.74 B
2016 Q3 489 329 M $10.8 B
2016 Q2 436 281 M $8.48 B
2016 Q1 412 254 M $7.15 B
2015 Q4 423 222 M $7.52 B
2015 Q3 404 204 M $6.48 B
2015 Q2 406 98.3 M $6.24 B
2015 Q1 420 89.8 M $6.16 B
2014 Q4 463 89.5 M $6.33 B
2014 Q3 479 76.3 M $5.45 B
2014 Q2 486 96.9 M $7.21 B
2014 Q1 421 116 M $7.59 B